Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Book:
Frontiers in CNS Drug Discovery
Page:
156-183
Author(s):
Karine Fabio, Christophe Guillon, Shi-fang Lu, Ned D. Heindel, Marvin Miller, Craig F. Ferris, Michael J. Brownstein and Carrie Gar
Pharmacological Treatment for Parkinson's Disease: A Continuing Evolution
Book:
Frontiers in CNS Drug Discovery
Page:
147-155
Author(s):
Quincy J. Almeida and H. Christopher Hyson
Alzheimer's Disease Drug Discovery: Potential Therapeutic Strategies and Future Treatments
Book:
Frontiers in CNS Drug Discovery
Page:
123-146
Author(s):
Laurent Lecanu and Vassilios Papadopoulos
Therapeutic Treatment of Alzheimer's Disease Using Metal Complexing Agents
Book:
Frontiers in CNS Drug Discovery
Page:
106-122
Author(s):
Katherine A. Price, Peter J. Crouch and Anthony R. White
Galantamine, a Natural Product for the Treatment of Alzheimer's Disease
Book:
Frontiers in CNS Drug Discovery
Page:
76-105
Author(s):
Luis Marco and Maria do Carmo Carreiras
Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Book:
Frontiers in CNS Drug Discovery
Page:
51-75
Author(s):
Jian Guan
Therapeutical Potentials of Protein Kinase C Activators as Antidementic and Cognition-Enhancing Agents
Book:
Frontiers in CNS Drug Discovery
Page:
31-50
Author(s):
Miao-Kun Sun and Daniel L. Alkon
Protective Substances Against Zinc-Induced Neuronal Death after Ischemia: Carnosine as a Target for Drug of Vascular Type of Dem
Book:
Frontiers in CNS Drug Discovery
Page:
21-30
Author(s):
Masahiro Kawahara, Keiko Konoha, Tetsuya Nagata and Yutaka Sadakane
Antiretroviral Therapy and HIV-1-Associated Dementia
Book:
Frontiers in CNS Drug Discovery
Page:
1-20
Author(s):
Michela Pollicita, Luigi Ronga, Valentina Svicher, Carlo Federico Perno and Stefano Aquaro
Contributors
Book:
Frontiers in CNS Drug Discovery
Page:
ii-ix
Author(s):
Bentham Science Publishers